CN112322531A - Production method and application of high-activity lactobacillus acidophilus freeze-dried powder - Google Patents

Production method and application of high-activity lactobacillus acidophilus freeze-dried powder Download PDF

Info

Publication number
CN112322531A
CN112322531A CN202011224084.9A CN202011224084A CN112322531A CN 112322531 A CN112322531 A CN 112322531A CN 202011224084 A CN202011224084 A CN 202011224084A CN 112322531 A CN112322531 A CN 112322531A
Authority
CN
China
Prior art keywords
lactobacillus acidophilus
culture
powder
freeze
culturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011224084.9A
Other languages
Chinese (zh)
Inventor
韩峰
郭仁妹
李仁靓
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Weike Life Technology Co ltd
Original Assignee
Suzhou Weike Life Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Weike Life Technology Co ltd filed Critical Suzhou Weike Life Technology Co ltd
Priority to CN202011224084.9A priority Critical patent/CN112322531A/en
Publication of CN112322531A publication Critical patent/CN112322531A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The invention relates to the technical field of lactobacillus acidophilus, in particular to a production method and application of high-activity lactobacillus acidophilus freeze-dried powder, wherein the process is simple, the obtained freeze-dried powder has large quantity of viable bacteria and high yield of thalli; the method comprises the following steps: s1, streaking and culturing lactobacillus acidophilus strains; s2, selecting dominant strains and culturing; s3, selecting dominant strains again and continuing culturing; s4, fermentation culture in a fermentation tank: selecting the single colony with a large calcium-dissolving ring on the plate in the step S3, inoculating the single colony into a selenium-rich culture medium, and culturing at 35-38 ℃ and pH of 5.5-6.0 for 48 h; s5, centrifugally concentrating the culture solution, and collecting bacterial sludge; s6, freeze-drying the centrifuged bacterial sludge, adding a protective agent, fully and uniformly mixing, carrying out vacuum freeze-drying, and taking out when the moisture content is extremely low; s7, crushing, sieving and packaging.

Description

Production method and application of high-activity lactobacillus acidophilus freeze-dried powder
Technical Field
The invention relates to the technical field of lactobacillus acidophilus, in particular to a production method and application of high-activity lactobacillus acidophilus freeze-dried powder.
Background
Lactobacillus acidophilus (Lactobacillus acidophilus, abbreviated as A bacteria) belongs to Lactobacillus in Lactobacillus family, is gram-positive bacteria, has slender rod shape, no flagellum, no motion, and is anaerobic or facultative anaerobic; it can utilize glucose, fructose, lactose and cane sugar to make homotype fermentation, and can produce DL-type lactic acid by means of fermentation.
The lactobacillus acidophilus regulates the micro-ecological environment from top to bottom in the whole gastrointestinal tract of a human body. "lower" means that they can also release substances that are beneficial for the growth of other probiotics such as bifidobacteria in the large intestine, increase the number of probiotics in the large intestine, and enhance their vitality.
Based on the fact that lactobacillus acidophilus has good nutrition and health care effects on human bodies, more and more enterprises take lactobacillus acidophilus freeze-dried powder as a food additive to prepare biological products and health food, and the number of living bacteria in a unit product directly influences the efficacy of the product. Therefore, it is important to increase the viable count during the production and preparation of the freeze-dried powder.
Selenium has various probiotic effects of resisting oxidation, improving the immunity of the organism and the like, certain probiotics can convert inorganic selenium into organic selenium, and because the probiotics can be conveniently added into food, sufficient selenium element can be supplemented for human bodies by taking a small amount of selenium-rich probiotics, the selenium-rich probiotic has good absorption effect and low toxicity, and simultaneously has double effects of organic selenium and probiotics.
Disclosure of Invention
In order to solve the technical problems, the invention provides a production method and application of high-activity lactobacillus acidophilus freeze-dried powder, the process is simple, the number of viable bacteria of the obtained freeze-dried powder is large, and the yield of thalli is high.
The invention relates to a production method of high-activity lactobacillus acidophilus freeze-dried powder, which comprises the following steps:
s1, streaking and culturing lactobacillus acidophilus strains: diluting lactobacillus acidophilus powder with sterile water, carrying out partition marking on an improved MC culture medium, inverting a plate after marking is finished, and carrying out constant-temperature culture in an incubator at 35 ℃ for 40-72 hours;
s2, selecting dominant strains for culture: selecting a single colony with a large calcium dissolving ring on a plate, inoculating the single colony on an improved MC culture medium, and carrying out partition scribing, inverting the plate after scribing is finished, and carrying out constant-temperature culture in a 35 ℃ incubator for 40-72 hours;
s3, selecting dominant strains again to culture continuously: selecting the single bacterial colony with the larger calcium dissolving ring on the plate in the step S2, inoculating the single bacterial colony on the improved MC culture medium, and carrying out partition scribing, wherein after the scribing is finished, the plate is inverted, and the single bacterial colony is cultured in a 35 ℃ incubator for 40-72 hours at constant temperature;
s4, fermentation culture in a fermentation tank: selecting the single colony with a large calcium-dissolving ring on the plate in the step S3, inoculating the single colony into a selenium-rich culture medium, and culturing at 35-38 ℃ and pH of 5.5-6.0 for 48 h;
s5, centrifugally concentrating the culture solution, and collecting bacterial sludge;
s6, freeze-drying the centrifuged bacterial sludge, adding a protective agent, fully and uniformly mixing, carrying out vacuum freeze-drying, and taking out when the moisture content is extremely low;
s7, crushing, sieving and packaging.
The invention relates to a production method of high-activity lactobacillus acidophilus freeze-dried powder, wherein in the steps S1, S2 and S3, the improved MC culture medium comprises 5.0g/L of soybean peptone, 3.0g/L of beef extract powder, 3.0g/L of yeast extract powder, 20.0g/L of lactose, 10.0g/L of calcium carbonate, 15.0g/L of agar, 10.0g/L of carrot extract, 10.0g/L of vitamin, 5g/L of casein hydrolysate and the balance of sterile water, the pH value is 5.0-7.0, and dilute hydrochloric acid or sodium hydroxide is used for adjusting the pH value.
The invention relates to a production method of high-activity lactobacillus acidophilus freeze-dried powder, wherein a selenium-rich culture medium in the step S4 comprises the following components: the selenium-rich culture medium in the step S4 comprises 5.0g/L of soybean meal, 3.0g/L of beef extract powder, 3.0g/L of yeast extract powder, 20.0g/L of pork kidney powder, 10.0g/L of broad bean powder, 10.0g/L of calcium carbonate, 10.0g/L of carrot extract, 10.0g/L of vitamin and 5g/L of casein hydrolysate, the balance of sterile water, the pH is 5.0-7.0, and the pH is adjusted by using dilute hydrochloric acid or sodium hydroxide.
In the steps S1, S2 and S3, sodium selenate is added after the culture is started for 10 hours in the culture process to ensure that the selenium concentration reaches 100 mug/ml.
The invention relates to a production method of high-activity lactobacillus acidophilus freeze-dried powder, and the protective agent in the step S6 comprises the following components: 70g/L of skimmed milk powder, 10g/L of cane sugar, 20g/L of stachyose, 10g/L of fructo-oligosaccharide, 10g/L of galacto-oligosaccharide, 5g/L of sodium ascorbate and the balance of sterile water.
According to the production method of the high-activity lactobacillus acidophilus freeze-dried powder, the inoculation amount in the step S4 is 6%.
The invention discloses application of high-activity lactobacillus acidophilus freeze-dried powder, and relates to application of high-activity lactobacillus acidophilus freeze-dried powder prepared by a production method in preparation of a medicine for treating diseases caused by intestinal dysbacteriosis.
Compared with the prior art, the invention has the beneficial effects that: firstly, through three times of culture, a strain with vigorous activity is selected, and through adding inorganic selenium for culture, the lactobacillus acidophilus converts the inorganic selenium into organic selenium in the body of the lactobacillus acidophilus, so that the activity of the lactobacillus acidophilus is enhanced, the immunity of the lactobacillus acidophilus is improved, and the activity of the lactobacillus acidophilus is higher; secondly, the selenium content in the lactobacillus acidophilus is further increased by culturing in a selenium-rich culture medium, so that the immunity of a user is improved, and the disease resistance is enhanced; thirdly, by adding stachyose, fructo-oligosaccharide and galacto-oligosaccharide, the sugar is a general term of linear chain component polymerized by 2-10 same or different monosaccharide units through glycosidic bonds or branched low-degree polymerized sugar, no enzyme metabolized in the human body is available in the sugar, so that the sugar and lactobacillus acidophilus directly enter the intestinal tract to be utilized by probiotics, become proliferation factors of the probiotics and promote the development of beneficial flora in the body.
Detailed Description
The following examples are given to further illustrate the embodiments of the present invention. The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.
Example 1:
the invention relates to a production method of high-activity lactobacillus acidophilus freeze-dried powder, which comprises the following steps:
s1, streaking and culturing lactobacillus acidophilus strains: diluting lactobacillus acidophilus powder with sterile water, partitioning and scribing on an improved MC culture medium (5.0 g/L of soybean peptone, 3.0g/L of beef extract powder, 3.0g/L of yeast extract powder, 20.0g/L of lactose, 10.0g/L of calcium carbonate, 15.0g/L of agar, 10.0g/L of carrot extract, 10.0g/L of vitamin, 5g/L of casein hydrolysate and the balance of sterile water), inverting a plate after scribing is finished, culturing for 56 hours at the constant temperature of a 35 ℃ culture box, and adding sodium selenate after 10 hours of culture is started to enable the selenium concentration to reach 100 mu g/ml;
s2, selecting dominant strains for culture: selecting a single colony with a large calcium dissolving ring on a plate, inoculating the single colony to an improved MC culture medium (5.0 g/L of soybean peptone, 3.0g/L of beef extract powder, 3.0g/L of yeast extract powder, 20.0g/L of lactose, 10.0g/L of calcium carbonate, 15.0g/L of agar, 10.0g/L of carrot extract, 10.0g/L of vitamin, 5g/L of casein hydrolysate and the balance of sterile water), carrying out partition streaking, after finishing the streaking, inverting the plate, carrying out constant-temperature culture in a 35 ℃ incubator for 70 hours, adding sodium selenate after beginning to carry out the culture for 10 hours, and enabling the selenium concentration to reach 100 mu g/ml;
s3, selecting dominant strains again to culture continuously: selecting a single colony with a large calcium dissolving ring on the plate in the step S2, inoculating the single colony to an improved MC culture medium (5.0 g/L of soybean peptone, 3.0g/L of beef extract powder, 3.0g/L of yeast extract powder, 20.0g/L of lactose, 10.0g/L of calcium carbonate, 15.0g/L of agar, 10.0g/L of carrot extract, 10.0g/L of vitamin, 5g/L of casein hydrolysate and the balance of sterile water), carrying out partition streaking, inverting the plate after the streaking is finished, carrying out constant-temperature culture in a 35 ℃ incubator for 62 hours, adding sodium selenate after 10 hours of culture is started, and enabling the selenium concentration to reach 100 mu g/ml;
s4, fermentation culture in a fermentation tank: selecting a single colony with a large calcium-dissolving ring on the plate in the step S3, inoculating the single colony into a selenium-rich culture medium (5.0 g/L of soybean meal, 3.0g/L of beef extract powder, 3.0g/L of yeast extract powder, 20.0g/L of pork kidney powder, 10.0g/L of broad bean powder, 10.0g/L of calcium carbonate, 10.0g/L of carrot extract, 10.0g/L of vitamin, 5g/L of casein hydrolysate and the balance of sterile water), wherein the inoculation amount is 6%, the temperature is 37 ℃, the pH value is 5.5-6.0, and the culture time is 48 h;
s5, centrifugally concentrating the culture solution, and collecting bacterial sludge;
s6, freeze-drying the centrifuged bacterial sludge, adding protective agents (70 g/L of skimmed milk powder, 10g/L of cane sugar, 20g/L of stachyose, 10g/L of fructo-oligosaccharide, 10g/L of galacto-oligosaccharide, 5g/L of sodium ascorbate and the balance of sterile water), fully mixing uniformly, carrying out vacuum freeze-drying, and taking out when the water content is extremely low through freeze-drying;
s7, crushing, sieving and packaging.
Example 2:
the difference from example 1 is that: the culture time in S1 was 50h, the culture time in S2 was 60h, the culture time in S3 was 50h, and the temperature in step S4 was 36 ℃.
Comparative example 1:
the difference from example 1 is that: sodium selenate is not added in the steps S1, S2 and S3;
comparative example 2:
the difference from example 1 is that: in step S4, soybean meal, pork kidney meal and broad bean meal are not added;
comparative example 3:
the difference from example 1 is that: sodium selenate is not added in steps S1, S2 and S3, and soybean meal, pork kidney meal and broad bean meal are not added in step S4;
the viable count of the lactobacillus acidophilus lyophilized powder prepared in examples 1-2 and comparative examples 1-3 was measured to obtain the following data:
Figure BDA0002763071360000051
from the data, when the steps S1, S2 and S3 are carried out simultaneously, a higher viable count can be obtained, which mainly comes from three times of culture, a strain with stronger activity is selected, and inorganic selenium is added for culture, so that the lactobacillus acidophilus converts the inorganic selenium into organic selenium in the body of the lactobacillus acidophilus, the activity of the lactobacillus acidophilus is enhanced, the immunity of the lactobacillus acidophilus is improved, and the activity of the lactobacillus acidophilus is higher;
the main reason for performing step S4 is to make lactobacillus acidophilus further absorb selenium and increase the selenium content in lactobacillus acidophilus, thereby increasing the selenium content in user' S body and achieving the purpose of preventing and treating diseases.
The above description is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, several modifications and variations can be made without departing from the technical principle of the present invention, and these modifications and variations should also be regarded as the protection scope of the present invention.

Claims (7)

1. A production method of high-activity lactobacillus acidophilus freeze-dried powder is characterized by comprising the following steps:
s1, streaking and culturing lactobacillus acidophilus strains: diluting lactobacillus acidophilus powder with sterile water, carrying out partition marking on an improved MC culture medium, inverting a plate after marking is finished, and carrying out constant-temperature culture in an incubator at 35 ℃ for 40-72 hours;
s2, selecting dominant strains for culture: selecting a single colony with a large calcium dissolving ring on a plate, inoculating the single colony on an improved MC culture medium, and carrying out partition scribing, inverting the plate after scribing is finished, and carrying out constant-temperature culture in a 35 ℃ incubator for 40-72 hours;
s3, selecting dominant strains again to culture continuously: selecting the single bacterial colony with the larger calcium dissolving ring on the plate in the step S2, inoculating the single bacterial colony on the improved MC culture medium, and carrying out partition scribing, wherein after the scribing is finished, the plate is inverted, and the single bacterial colony is cultured in a 35 ℃ incubator for 40-72 hours at constant temperature;
s4, fermentation culture in a fermentation tank: selecting the single colony with a large calcium-dissolving ring on the plate in the step S3, inoculating the single colony into a selenium-rich culture medium, and culturing at 35-38 ℃ and pH of 5.5-6.0 for 48 h;
s5, centrifugally concentrating the culture solution, and collecting bacterial sludge;
s6, freeze-drying the centrifuged bacterial sludge, adding a protective agent, fully and uniformly mixing, carrying out vacuum freeze-drying, and taking out when the moisture content is extremely low;
s7, crushing, sieving and packaging.
2. The method of claim 1, wherein the modified MC medium of steps S1, S2, and S3 comprises soy peptone 5.0g/L, beef extract 3.0g/L, yeast extract 3.0g/L, lactose 20.0g/L, calcium carbonate 10.0g/L, agar 15.0g/L, carrot extract 10.0g/L, vitamins 10.0g/L, and casein hydrolysate 5g/L, and the balance is sterile water, pH is 5.0-7.0, and pH is adjusted with diluted hydrochloric acid or sodium hydroxide.
3. The method for producing highly active lactobacillus acidophilus lyophilized powder of claim 2, wherein the selenium-rich medium of step S4 comprises: the selenium-rich culture medium in the step S4 comprises 5.0g/L of soybean meal, 3.0g/L of beef extract powder, 3.0g/L of yeast extract powder, 20.0g/L of pork kidney powder, 10.0g/L of broad bean powder, 10.0g/L of calcium carbonate, 10.0g/L of carrot extract, 10.0g/L of vitamin and 5g/L of casein hydrolysate, the balance of sterile water, the pH is 5.0-7.0, and the pH is adjusted by using dilute hydrochloric acid or sodium hydroxide.
4. The method of claim 3, wherein during the culturing steps S1, S2 and S3, sodium selenate is added after 10 hours of culturing to make selenium concentration reach 100 μ g/ml.
5. The method for producing highly active lactobacillus acidophilus lyophilized powder of claim 4, wherein the protective agent in step S6 comprises: 70g/L of skimmed milk powder, 10g/L of cane sugar, 20g/L of stachyose, 10g/L of fructo-oligosaccharide, 10g/L of galacto-oligosaccharide, 5g/L of sodium ascorbate and the balance of sterile water.
6. The method of claim 5, wherein the inoculation amount in step S4 is 6%.
7. Use of highly active lactobacillus acidophilus lyophilized powder prepared by the method of any of claims 1 to 6 for the preparation of a medicament for the treatment of disorders caused by a disturbance of intestinal flora.
CN202011224084.9A 2020-11-05 2020-11-05 Production method and application of high-activity lactobacillus acidophilus freeze-dried powder Pending CN112322531A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011224084.9A CN112322531A (en) 2020-11-05 2020-11-05 Production method and application of high-activity lactobacillus acidophilus freeze-dried powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011224084.9A CN112322531A (en) 2020-11-05 2020-11-05 Production method and application of high-activity lactobacillus acidophilus freeze-dried powder

Publications (1)

Publication Number Publication Date
CN112322531A true CN112322531A (en) 2021-02-05

Family

ID=74315919

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011224084.9A Pending CN112322531A (en) 2020-11-05 2020-11-05 Production method and application of high-activity lactobacillus acidophilus freeze-dried powder

Country Status (1)

Country Link
CN (1) CN112322531A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113956996A (en) * 2021-08-03 2022-01-21 镇江市远胜生物工程有限公司 Production method of freeze-dried lactobacillus acidophilus powder

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106701642A (en) * 2017-03-01 2017-05-24 汉臣氏(沈阳)儿童制品有限公司 Preparation method of lactobacillus acidophilus freeze-dried powder
CN109770363A (en) * 2019-03-15 2019-05-21 陕西科技大学 A kind of nanometer selenium Freeze-dry Powder of Probioctics and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106701642A (en) * 2017-03-01 2017-05-24 汉臣氏(沈阳)儿童制品有限公司 Preparation method of lactobacillus acidophilus freeze-dried powder
CN109770363A (en) * 2019-03-15 2019-05-21 陕西科技大学 A kind of nanometer selenium Freeze-dry Powder of Probioctics and preparation method thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
宋照军: "乳酸菌富硒技术初步研究", 《食品科学》 *
朱俊晨: "嗜酸乳杆菌的生长与富硒的动态关系研究", 《中国微生态学杂志》 *
汪波等: "3种乳酸菌鉴定、筛选、富硒比较研究", 《中国农学通报》 *
王丽红等: "3种益生菌转化纳米硒冻干菌粉工艺研究与形态表征", 《食品科技》 *
王丽红等: "微生物还原法合成纳米硒益生菌的筛选及其培养条件优化", 《陕西科技大学学报》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113956996A (en) * 2021-08-03 2022-01-21 镇江市远胜生物工程有限公司 Production method of freeze-dried lactobacillus acidophilus powder

Similar Documents

Publication Publication Date Title
CN1099289C (en) Medicinal prepn. contg. beneficial bacteria named 'Junyikang' and method for preparing same
CN105146614A (en) Functional Chinese dwarf cherry seed ferment, ferment beverage and production method of ferment beverage
CN106222158B (en) Preparation method of lactobacillus-embedding microcapsule
CN108783462A (en) A kind of industrial process of beneficial bacteria of intestinal tract preparation
CN108823129B (en) A kind of high-activity probiotics solid beverage with disinfecting helicobacter pylori effect
CN104542977B (en) A kind of health beverages and preparation method containing yam extract and bifidobacterium bifidum
CN101671638B (en) New strain of bifidobacterium and fermentative preparation method and application thereof
CN101366734A (en) Synbiotics medicament composition
CN105018408B (en) It is a kind of to add the method that rutin promotes growth of probiotics in the medium
CN110564638A (en) Lactobacillus reuteri with probiotic characteristics and application thereof
CN101974463B (en) Lactobacillus reuteri and composite viable bacteria preparation thereof
CN113142302B (en) Probiotic yogurt with blood glucose reducing effect and preparation method thereof
CN107988123A (en) One plant has the lactobacillus plantarum for adjusting ampicillin induction enteric flora disturbance
CN107312732A (en) A kind of probiotic feed additive
CN107164295A (en) A kind of selenium-enriched microbe its preparation method and application
CN111254088A (en) Bacillus coagulans strain and application thereof
CN110959867A (en) Composite probiotic microcapsule powder for emulsification and preparation method and application thereof
CN110157650A (en) The bifidobacterium lactis M8 of one plant of isolated from mother's milk and its application
CN110200186B (en) Probiotic solid beverage and preparation method thereof
CN111635875A (en) Bifidobacterium longum CZ70 and method for preparing live bacterial blackberry fruit pulp by using same
CN102907585A (en) Probiotics and vitamin premix and mixture for middle pig
CN108795823B (en) It is a kind of improve women pregnant and lying-in women's intestinal flora probiotics cultural method and application
CN116855413B (en) Bioactive substance for regulating human body microecological balance prepared from lactobacillus rhamnosus YSs069 and application thereof
CN112322531A (en) Production method and application of high-activity lactobacillus acidophilus freeze-dried powder
CN107189966A (en) A kind of probiotics and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210205